GW3965 HYDROCHLORIDE NO FURTHER A MYSTERY

All enrolled clients who obtained a minimum of just one dose of zosuquidar or placebo all through induction had been monitored to the incidence of adverse situations (439 individuals, 219 on zosuquidar and 210 on placebo). The most common adverse activities ended up related to the duration of extended and significant myelosuppression as is anticipa